Dashboard
Company has a low Debt to Equity ratio (avg) at 0 times
Positive results in Sep 25
With ROE of 14.8, it has a Very Attractive valuation with a 2.3 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Computers - Software & Consulting
INR 1,636 Cr (Small Cap)
16.00
28
4.75%
-0.40
14.79%
2.32
Total Returns (Price + Dividend) 
Latest dividend: 50 per share ex-dividend date: Feb-12-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Expleo Solutions Sees Revision in Market Evaluation Amid Mixed Financial Signals
Expleo Solutions has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of mixed performance indicators, including valuation attractiveness and recent financial trends, which have influenced the stock’s standing within the Computers - Software & Consulting sector.
Read MoreIs Expleo Solutions overvalued or undervalued?
As of 17 November 2025, Expleo Solutions has moved from an attractive to a very attractive valuation grade. The company is currently undervalued, with a PE ratio of 16.52, an EV to EBITDA of 9.27, and a dividend yield of 4.51%. In comparison to its peers, TCS has a PE ratio of 22.32 and an EV to EBITDA of 15.69, while Wipro, also rated very attractive, has a PE ratio of 18.95 and an EV to EBITDA of 12.43. Despite a challenging year-to-date performance of -21.10% compared to the Sensex's 8.72%, Expleo Solutions shows strong fundamentals with a ROCE of 28.39% and a ROE of 14.79%. These metrics indicate that the company is well-positioned for growth, reinforcing its undervalued status in the current market....
Read MoreHow has been the historical performance of Expleo Solutions?
Answer: The historical performance of Expleo Solutions shows a consistent growth trajectory in net sales and profits over the years. Breakdown: Expleo Solutions has demonstrated significant growth in net sales, increasing from 270.22 Cr in Mar'20 to 1,024.80 Cr in Mar'25. The total operating income followed a similar trend, reaching 1,024.80 Cr in Mar'25, up from 270.22 Cr in Mar'20. Total expenditure, excluding depreciation, also rose from 217.00 Cr in Mar'20 to 859.13 Cr in Mar'25, reflecting the company's expansion efforts. Operating profit (PBDIT) peaked at 181.87 Cr in Mar'25, although it was lower than the previous year's 216.25 Cr. Profit before tax reached 139.24 Cr in Mar'25, up from 54.06 Cr in Mar'20, while profit after tax was 103.24 Cr in Mar'25, showing an increase from 39.90 Cr in Mar'20. The company's total assets grew from 212.58 Cr in Mar'20 to 818.17 Cr in Mar'25, with total liabilities ...
Read More Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
19-Nov-2025 | Source : BSEReference to our earlier intimation letter SEC/SE/074/25-26 dated November 14 2025 relating to the audio recording of Analyst or Investor Call and pursuant to the requirement of Regulation 30 read with Part A of Schedule III and Regulation 46(2)(oa) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the transcript of the Investor Call held on November 14 2025 is available on the Companys Website at https://expleogroup.com/expleo-solutions/media-center/.
Announcement under Regulation 30 (LODR)-Investor Presentation
14-Nov-2025 | Source : BSEAttached is the Investor Presentation of the Company for the quarter and half year ended September 30 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2025 | Source : BSENewspaper Publication for Q2-FY 2025-26 of Expleo Solutions Limited
Corporate Actions 
No Upcoming Board Meetings
Expleo Solutions Ltd has declared 500% dividend, ex-date: 12 Feb 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 15 FIIs (0.13%)
Expleo Technology Germany Gmbh (71.05%)
None
22.6%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 8.88% vs 1.51% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 94.62% vs -15.16% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.05% vs 11.36% in Sep 2024
Growth in half year ended Sep 2025 is 1.33% vs 59.27% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 8.39% vs 5.54% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 10.99% vs -29.12% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 6.21% vs 6.82% in Mar 2024
YoY Growth in year ended Mar 2025 is 14.15% vs -32.45% in Mar 2024






